Praxis Precision Medicines, Inc. (PRAX) › Cash & EquivalentsPraxis Precision Medicines, Inc. (PRAX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2019: $44.81M2020: $296.61M2021: $138.70M2022: $61.62M2023: $81.30M2024: $215.37M2025: $357.33M$357.33M2019Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$357.33M+65.9%2024$215.37M+164.9%2023$81.30M+31.9%2022$61.62M-55.6%2021$138.70M-53.2%2020$296.61M+561.8%2019$44.81M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share